HEMISPHERX BIOPHARMA (HEB) analyst actions
Rating and price-target actions on HEB in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the HEB overview →
No HEB analyst action events in the measured window.
Nothing matched in the current window — the HEB overview has every event we measure for this name.
Get an email when HEB moves on news →Keep exploring
More HEB: earnings → · SEC filings → · HEB overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (Delaware) (ATNM) | 784 | 0.00% | 45% |
| Heat Biologics, Inc. (HTBX) | 781 | -0.40% | 41% |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) | 777 | -0.09% | 47% |
| Aldeyra Therapeutics, Inc. (ALDX) | 774 | +0.03% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.